672 Letters in Organic Chemistry, 2013, Vol. 10, No. 9
Wu and Shen
Med. Chem., 2009, 52, 170-180; (c) Aiello, S.; Wells, G.; Stone,
E.L.; Kadri, H.; Bazzi, R.; Bell, D.R.; Stevens, M.F.G.; Matthews,
C.S.; Bradshaw, T.D.; Westwell, A.D. Synthesis and biological
properties of benzothiazole, benzoxazole, and chromen-4-one ana-
logues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-
fluorobenzothiazole (PMX610, NSC 721648). J. Med. Chem.,
2008, 51, 5135-5139; (d) Van Zandt, M.C.; Jones, M.L.; Gunn,
D.E.; Geraci, L.S.; Jones, J.H.; Sawicki, D.R.; Sredy, J.; Jacot, J.L.;
DiCioccio, A.T.; Petrove, T.; Mitschler, A.; Podjarny, A.D. Dis-
covery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-N-
acetic acid (Lidorestat) and congeners as highly potent and selec-
tive inhibitors of aldose reductase for treatment of chronic diabetic
complications. J. Med. Chem., 2005, 48, 3141-3152; (e) Mortimer,
C.G.; Wells, G.; Crochard, J.-P.; Stone, E.L.; Bradshaw, T.D.; Ste-
vens, M.F.G.; Westwell, A.D. Antitumor benzothiazoles. 26. 2-
110.5, 119.9, 124.5, 124.8, 125.0, 128.2, 128.8, 132.3, 138.7,
142.1, 150.7, 163.2; GC-MS (EI, m/z): 229 [M+].
2-Phenyl-1-methyl-1H-benzo[d]imidazole[5b]
1
White solid, mp 92-94°C (lit.: 94.7°C); H NMR (300
MHz, CDCl3): ꢀ 3.88 (s, 3H), 7.30-7.37 (m, 2H), 7.38-7.42
(m, 1H), 7.48-7.57 (m, 3H), 7.75-7.80 (m, 3H), 7.80-7.88
(m, 1H). 13C NMR (CDCl3, 75MHz): ꢀ 31.7, 109.6, 119.9,
122.4, 122.7, 128.7, 129.5, 129.7, 130.2, 136.6, 143.0, 153.8.
2-(p-Tolyl)-1-methyl-1H-benzo[d]imidazole[5a]
1
White solid, mp 125-127°C (lit.: 127-128°C); H NMR
(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole
(GW
610,
(300 MHz, CDCl3): ꢀ 2.44 (s, 3H), 3.87 (s, 3H), 7.30-7.40
(m, 5H), 7.65-7.68 (m, 2H), 7.82-7.85 (m, 1H); 13C NMR
(CDCl3, 75MHz): ꢀ 21.5, 31.7, 109.6, 119.6, 122.5, 122.6,
127.3, 129.3, 129.4, 136.6, 140.0, 142.5, 153.9; GC-MS (EI,
m/z): 223 [M+].
NSC721648), a simple fluorinated 2-arylbenzothiazole, shows po-
tent and selective inhibitory activity against lung, colon, and breast
cancer cell lines. J. Med. Chem., 2006, 49, 179-185; (f) Dunn, G.
L.; Actor ,P.; DiPasquo, V. J. Antiparasitic agents. I. 2-(Nitro-
heterocyclic) benzimidazoles, benzoxazoles, and benzothiazoles. J.
Med. Chem., 1966, 9, 751-753; (g) Katz, L. Antituberculous com-
pounds. III. Benzothiazole and benzoxazole derivatives. J. Am.
Chem. Soc., 1953, 75, 712-714.
(a) Rodionov, V. O.; Presolski, S. I.; Gardinier, S.; Lim, Y.-H.;
Finn, M. G. Benzimidazole and related ligands for Cu-catalyzed az-
ide-alkyne cycloaddition. J. Am. Chem. Soc., 2007, 129, 12696-
12704;; (b) Komatsu, K.; Urano, Y.; Kojima, H.; Nagano, T. De-
velopment of an iminocoumarin-based zinc sensor suitable for rati-
ometric fluorescence imaging of neuronal zinc. J. Am. Chem. Soc.,
2007, 129, 13447-13454; (c) Suh, J.; Yoo, S. H.; Kim, M. G.;
Jeong, K.; Ahn, J. Y.; Kim, M.-S.; Chae, P. S.; Lee, T. Y.; Lee, J.;
Lee, J.; Jang, Y. A.; Ko, E. H. Cleavage agents for soluble oli-
gomers of amyloid ꢁ peptides. Angew. Chem. Int. Ed., 2007, 46,
7064-7067; (d) Mori, A.; Sekiguchi, A.; Masui, K.; Shimada, T.;
Horie, M.; Osakada, K.; Kawamoto, M.; Ikeda, T. Facile synthesis
of 2,5-diarylthiazoles via palladium-catalyzed tandem C-H substi-
tutions. Design of tunable light emission and liquid crystalline
characteristics. J. Am. Chem. Soc., 2003, 125, 1700-1701.
2-(4-Chlorophenyl)-1-methyl-1H-benzo[d]imidazole[5a]
[2]
1
White solid, mp 111-113°C (lit.: 112-113°C); H NMR
(300 MHz, CDCl3): ꢀ 3.90 (s, 3H), 7.33-7.49 (m, 5H), 7.65-
7.67 (m, 1H), 7.80-7.85 (m, 2H); 13C NMR (CDCl3,
75MHz): ꢀ 31.6, 109.7, 120.0, 122.7, 123.2, 127.5, 129.5,
129.8, 129.9, 134.8, 136.5, 142.8, 152.5; GC-MS (EI, m/z):
243 [M+].
4,5-Dimethyl-2-phenylthiazole[5i]
1
Colorless oil; H NMR (300 MHz, CDCl3): ꢀ 2.40 (s,
6H), 7.26-7.42 (m, 3H), 7.87-7.89 (m, 2H); 13C NMR
(CDCl3, 75MHz): ꢀ 11. 5, 14.8, 126.1, 126.5, 128.7, 129.3,
133.9, 149.2, 163.3; GC-MS (EI, m/z): 189.
[3]
(a) Ma, D.; Xie, S.; Xue, P.; Zhang, X.; Dong, J.; Jiang, Y. Effi-
cient and economical access to substituted benzothiazoles: copper-
catalyzed coupling of 2-haloanilides with metal sulfides and subse-
quent condensation. Angew. Chem. Int. Ed., 2009, 48, 4222-4225;
(b) Itoh, T.; Mase, T. A novel practical synthesis of benzothiazoles
via Pd-catalyzed thiol cross-coupling. Org. Lett., 2007, 9, 3687-
3689; (c) Zou, B.; Yuan, Q.; Ma, D. Synthesis of 1,2-disubstituted
4,5-Dimethyl-2-(4-methylphenyl)thiazole[9,12]
1
Colorless solid, mp 56-58°C (lit.:56-57°C); H NMR
(300 MHz, CDCl3): ꢀ 2.37 (s, 9H), 7.20 (d, J = 7.8 Hz, 2H),
7.76 (d, J = 7.8 Hz, 2H); 13C NMR (CDCl3, 75MHz): ꢀ 11.4,
14.7, 21.3, 125.9, 126.1, 129.4, 131.3, 139.4, 149.0, 163.5;
GC-MS (EI, m/z): 203 [M+].
benzimidazoles by
a
Cu-catalyzed cascade aryl amina-
tion/condensation process. Angew. Chem. Int. Ed., 2007, 46, 2598-
2601; (d) Chen, Y.; Xie, X.; Ma, D. Facile access to polysubsti-
tuted indoles via a cascade Cu-catalyzed arylation-condensation
process. J. Org. Chem., 2007, 72, 9329-9334;(e) Evindar, G.;
Batey, R. A. Parallel synthesis of a library of benzoxazoles and
benzothiazoles using ligand-accelerated copper-catalyzed cycliza-
tions of ortho-halobenzanilides. J. Org. Chem., 2006, 71, 1802-
1808; (f) Rudrawar, S.; Kondaskar, A.; Chakraborti, A. K. An effi-
cient acid- and metal-free one-pot synthesis of benzothiazoles from
carboxylic acids. Synthesis, 2005, 2521-2526; (g) Abbotto, A.;
Bradnmante, S.; Facchetti, A.; Pagani, G. A. Metal chelation apti-
tudes of bis(o-azaheteroaryl)methanes as tuned by heterocycle
charge demands. J. Org. Chem., 2002, 67, 5753-5772; (h) Ben-
Alloum, A.; Bakkas, S.; Soufiaoui, M. Novel synthesis of 2-
arylbenzothiazoles- Microwave-activated electron transfer. Tetra-
hedron Lett., 1997, 38, 6395-6396; (i) Boger, D. E. A convenient
preparation of 2-substituted benzothiazoles. J. Org. Chem., 1978,
43, 2296-2297.
CONFLICT OF INTEREST
The authors confirm that this article content has no con-
flict of interest.
ACKNOWLEDGEMENTS
This work was supported by the Natural Science Founda-
tion of Zhejiang Province (NO. LY13B020005).
REFERENCES
[4]
[5]
(a) Alberico, D.; Scott, M. E.; Lautens, M. Aryl-aryl bond forma-
tion by transition-metal-catalyzed direct arylation. Chem. Rev.,
2007, 107, 174-238; (b) Colby, D. A.; Bergman, R. G.; Ellman, J.
A. Rhodium-catalyzed C-C bond formation via heteroatom-
directed C-H bond activation. Chem. Rev., 2010, 110, 624-655; (c)
Lyons, T. W.; Sanford, M. S. Palladium-catalyzed ligand-directed
C-H functionalization reactions. Chem. Rev., 2010, 110, 1147-
1169.
[1]
(a) Tzanopoulou, S.; Sagnou, M.; Paravatou-Petsotas, M.; Gourni,
E.; Loudos, G.; Xanthopoulos, S.; Lafkas, D.; Kiaris, H.; Var-
varigou, A.; Pirmettis, I. C.; Papadopoulos, M.; Pelecanou, M.
Evaluation of Re and 99mTc complexes of 2-(4-
aminophenyl)benzothiazole as potential breast cancer radiophar-
maceuticals. J. Med. Chem., 2010, 53, 4633-4641; (b) Wang, X.;
Sarris, K.; Kage, K.; Zhang, D.; Brown, S.P.; Kolasa, T.; Surowy,
C.; Kouhen, O.F.E.; Muchmore, S.W.; Brioni, J.D.; Stewart, A.O.
Synthesis and evaluation of benzothiazole-based analogues as
novel, potent, and selective fatty acid amide hydrolase inhibitors. J.
(a) Zhang, W.; Zeng, Q. L.; Zhang, X. M.; Tian, Y. J.; Yue, Y.;
Guo, Y. J.; Wang, Z. H. Ligand-free CuO nanospindle catalyzed
arylation of heterocycle C-H bonds. J. Org. Chem., 2011, 76, 4741-